Despite the rapidly increasing capacity to sequence human genomes, our incomplete ability to read and interpret the information content in genomes and epigenomes remain a central challenge. A comprehensive set of regulatory events across a genome - the regulome - is needed to make full use of genomic information, but is currently out of reach for practically all clinical applications and many biological systems The proposed Center will develop technologies that greatly increase the sensitivity, speed, and comprehensiveness of understanding genome regulation. We will develop new technologies to interrogate the transactions between the genome and regulatory factors, such as proteins and noncoding RNAs, and integrate variations in DNA sequences and chromatin states over time and across individuals. Novel molecular engineering and biosensor strategies are deployed to encapsulate the desired complex DNA transformations into the probe system, such that the probe system can be directly used on very small human clinical samples and capture genome-wide information in one or two steps. These technologies will be applied to clinical samples and workflows in real time to exercise their robustness and reveal for the first time epigenomic dynamics of human diseases during progression and treatment. These technologies will be broadly applicable to many biomedical investigations, and the Center will disseminate the technologies via training and diverse means.
How genes are turned on and off govern the outcome and treatments of many human diseases. By making it possible to track all the genetic switches rapidly and comprehensively from small human biopsies, the Center aims to greatly improve the precision and effectiveness of disease diagnosis and treatment, such as for cancer, autoimmunity, and neurodegenerative diseases.
|Satpathy, Ansuman T; Saligrama, Naresha; Buenrostro, Jason D et al. (2018) Transcript-indexed ATAC-seq for precision immune profiling. Nat Med 24:580-590|
|Calo, Eliezer; Gu, Bo; Bowen, Margot E et al. (2018) Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders. Nature 554:112-117|
|Chen, Xingqi; Litzenburger, Ulrike M; Wei, Yuning et al. (2018) Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneity. Nat Commun 9:4590|
|Koh, Andrew S; Miller, Erik L; Buenrostro, Jason D et al. (2018) Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol 19:162-172|
|Corces, M Ryan; Granja, Jeffrey M; Shams, Shadi et al. (2018) The chromatin accessibility landscape of primary human cancers. Science 362:|
|Pattison, Jillian M; Melo, Sandra P; Piekos, Samantha N et al. (2018) Retinoic acid and BMP4 cooperate with p63 to alter chromatin dynamics during surface epithelial commitment. Nat Genet 50:1658-1665|
|Zhang, Wei; Bojorquez-Gomez, Ana; Velez, Daniel Ortiz et al. (2018) A global transcriptional network connecting noncoding mutations to changes in tumor gene expression. Nat Genet 50:613-620|
|Rubin, Adam J; Parker, Kevin R; Satpathy, Ansuman T et al. (2018) Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks. Cell :|
|Zhou, Bo; Arthur, Joseph G; Ho, Steve S et al. (2018) Extensive and deep sequencing of the Venter/HuRef genome for developing and benchmarking genome analysis tools. Sci Data 5:180261|
|Duren, Zhana; Chen, Xi; Zamanighomi, Mahdi et al. (2018) Integrative analysis of single-cell genomics data by coupled nonnegative matrix factorizations. Proc Natl Acad Sci U S A 115:7723-7728|
Showing the most recent 10 out of 117 publications